Real-time glucose monitoring with group support during pregnancy
Official title: Real-time Continuous Glucose Monitoring and Mobile-based Social Support to Promote Glucose Management During Pregnancy
Run by Tufts Medical Center · NCT07009704 · Data updated 2026-11-12
This program will test whether wearing a real-time glucose monitor and joining a group chat helps pregnant people at risk for gestational diabetes keep their blood sugar in a healthy range.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 70 (estimated) |
| Sponsor | Tufts Medical Center Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | May 2027 |
| Study ends | July 2027 |
| Registry record updated | November 9, 2026 |
| Trial ID | NCT07009704 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant people under 20 weeks' gestation, aged 18–45, with BMI >25 or a personal or first-degree family history of type 2 diabetes who own a smartphone, are comfortable in English, and plan prenatal care and delivery at Tufts Medical Center.
✕Probably not a fit
Those with preexisting diabetes, multiple gestation pregnancies, certain active infections or substance use, prior gastric bypass, chronic illnesses requiring regular medication or dialysis, shift work that alters sleep, or those not planning to deliver at Tufts or without a smartphone are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants early in pregnancy (<20 weeks) wear a continuous glucose monitor that streams real-time glucose levels to a smartphone app and join a mobile group chat for peer support. The intervention combines immediate glucose feedback with social messaging to prompt short-term actions (for example, walking or drinking water) and to share dietary and self-care tips. Investigators will track glucose patterns, engagement with the app and chat, and pregnancy outcomes to see if the combined approach helps maintain healthier blood glucose. The program is delivered via participants' own smartphones and run through Tufts Medical Center with follow-up through delivery.
Why it matters
Potential benefit: If successful, this approach could help lower high blood sugar during pregnancy and reduce the risk of complications for both parent and baby.
How similar studies have gone: Continuous glucose monitoring has improved glucose detection and control in pregnancy in prior work, but pairing real-time CGM with a structured peer group chat is a relatively novel combination.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant (\<20w0d) * At least 18 years to 45 years old * BMI \>25, personal history of GDM, or first-degree family member with type II diabetes * Comfortable conversing in English * Own a smartphone and willing to use the CGM app and Signal * Receiving prenatal care and planning to deliver at Tufts Medicine (Boston) * Signed the consent form * Currently located in the United States Exclusion Criteria: * Current pregnancy a multiple gestation (e.g., twins) * Smoked during this current pregnancy * Active hepatitis or HIV infection * Current pregnancy have any documented fetal congenital anomalies * Current history of heroin, cocaine, crack, LSD, or methamphetamines * Current history of alcohol abuse * Previous gastric bypass * Shift work that alters the sleep/wake periods * Have known rheumatological or chronic inflammatory state (i.e., arthritis, inflammatory bowel disease)? * Chronic illnesses, including diabetes and dialysis, that require regular medication use * Uncontrolled hypothyroidism * Known culture of positive chorioamnionitis? * An adult who is unable to consent (e.g., cognitively impaired adults) * Ward of the state * Unable to read or write English
Where it's running
-
Tufts Medical Center
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Larissa Calancie, PhD
- Email: larissa.calancie@tufts.edu
- Phone: (617) 636-0976
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Delivering HOPE: healthy food and grocery support during pregnancy
This project will test whether providing pregnant people with healthy food and grocery funds during pregnancy reduces excessive weight gain compared with enhanced usual care.
-
Examining how aspirin metabolism relates to metabolic dysfunction in pregnant individuals at risk of preeclampsia
This study is trying to see how the way pregnant people process aspirin relates to their metabolic health and the health of their babies, especially for those at risk of preeclampsia.
-
Comparing early and late blood glucose monitoring in pregnant women with a history of gestational diabetes
This study tests if pregnant women with a history of gestational diabetes do better when they monitor their blood sugar early in pregnancy instead of waiting until later.
-
Understanding Gestational Diabetes in Asian Pregnant Women
This study is trying to learn more about gestational diabetes in Asian pregnant women to see how different types of the condition affect their health and treatment options.
-
Improving oral health during pregnancy to prevent complications
This study tests if treating gum disease in pregnant women can help their babies grow better and lower the chances of early delivery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.